What we do
We hold six specialised units: plant production, food biotechnology, cosmetics, laboratory tools, biomedical research and the automation of living systems.
Mexican biotechnology group · Demand-validation stage
A greener planet through science inspired by life.
The technology already runs inside every living organism. Our job is to understand it, test it, and translate only what survives the test.
Status of our claims on this page
This site can be audited.
- 4 Verified Evidence exists and we can show it.
- 4 In validation A hypothesis with a plan and an owner. No result yet.
- 4 Not built yet It is in the plan. It does not exist today and we will not imply otherwise.
We do not publish a single capability without stating where it stands. The count below maps, row by row, to the evidence table and to EVIDENCIA.md in the repository.
If something changes status, it changes here and in the document.
In thirty seconds
What 3 Marías is, and who it exists for.
Who it is for
Growers and micropropagation labs, food and personal-care companies, research groups, technical distributors, and organisations that already have a biological problem and a budget to test it.
How we work
First we separate what we know from what we assume. Then we turn the assumption into a test with a success criterion defined before we start.
The six units
Six paths out of one intelligence.
Every unit declares its status. None is presented as finished unless it is.
01
Verified
Integrated plant production
3 MARIAS FARMS
Field, greenhouse and laboratory. In-vitro propagation, acclimatisation and plant material selected per species and production system.
02
In validation
Biotechnology for the food industry
FRUCTUM
Systems to delay oxidation, substitutes for higher-risk inputs, and measurable reduction of microplastic exposure.
03
In validation
Cosmetic biotechnology
VITRÉA
Bioactive concepts with a defined route for formulation, stability and sensory evaluation.
04
In validation
Laboratory solutions
TRIVITRA
Inputs, tools and implementation support for micropropagation workflows.
05
Not built yet
Biomedical research
TRIMED
Research inspired by biology, aimed at wounds, infections and unresolved medical needs.
06
Not built yet
Automation of living systems
VERDÉA
Sensors, environmental control and automation for home, garden, greenhouse and plantation.
The real status
What exists today, what we are testing, and what does not exist yet.
This is the section that costs us the most and distinguishes us the most. A technical buyer deserves to know where the evidence ends and the intention begins.
Verified
Exists today
- Plant production in field, greenhouse and laboratory.
- Documented micropropagation protocols.
- This page, which declares its own status.
In validation
In validation
- Five product lines, each with its success criterion.
- Real demand and willingness to pay from founding organisations.
- Regulatory routes per market and per unit.
Not built yet
Does not exist yet
- No product approved by any regulatory authority.
- No third-party certification.
- No list price and no public catalogue.
View all twelve claims with their source 4 · 4 · 4
The complete table, row by row. It is the same one that governs this page's content.
Verified4In validation4Not built yet4
12 declared claims
| Claim | Status | What we have |
|---|---|---|
| We produce plant material in laboratory, greenhouse and field. | Verified | Laboratory protocols and internal production records. |
| We operate a plant tissue-culture laboratory. | Verified | Laboratory manual and in-vitro culture technical documentation. |
| We handle in-vitro propagation and acclimatisation per species. | Verified | Per-species protocols and documented acclimatisation series. |
| We hold six specialised units under a single structure. | Verified | Corporate structure and this documented delivery. |
| Demand willing to pay for our lines exists. | In validation | Conversations with founding organisations, underway. |
| Our protocols are reproducible at commercial scale. | In validation | Under test. Requires repeated runs at scale. |
| We measurably reduce exposure to microplastics. | In validation | Active workstream. No publishable result yet. |
| Cosmetic concepts pass stability and sensory evaluation. | In validation | Validation route defined. No completed studies. |
| We have a product approved by a regulatory authority. | Not built yet | Does not exist. No unit holds sanitary approval to date. |
| We hold third-party certifications. | Not built yet | Does not exist. No external audit performed. |
| Our cosmetic concepts have proven efficacy. | Not built yet | Does not exist. Requires efficacy studies not yet performed. |
| We operate a VERDÉA automation platform in production. | Not built yet | Does not exist. Concept and architecture defined, no product running. |
The full version, with the documentary detail behind each row, lives in EVIDENCIA.md inside this delivery.
The plan
What we intend to do with this intelligence.
Four phases with a decision gate between each. If the gate does not open, we do not advance: we change course and say so.
-
00
Demand validation
UnderwayConversations with founding organisations to identify the highest-value problems and discard the ones that are not.
Gate: three problems with stated willingness to pay.
In validation -
01
First concept programmes
2026Turn each prioritised problem into an experimental brief with evidence milestones and a success criterion agreed before starting.
Gate: one reproducible result per programme.
Not built yet -
02
Development partnerships
2027Scale what survived the test, with programme architecture, operating controls and a defined commercial route.
Gate: repeatable delivery at a known cost.
Not built yet -
03
Approvals by market
2027 onwardSubmit to the appropriate regulatory routes only what already holds enough evidence to support a claim.
Gate: complete dossier per jurisdiction.
Not built yet
Living technology
Four billion years of research and development came before us.
LUCA — the last universal common ancestor — connects every known branch of life. DNA still carries that continuity: an information system able to copy, adapt and diversify.
The opportunity is not to imitate nature superficially. It is to understand mechanisms, test them, and translate only what works.
This diagram is drawn with SVG and is visible without JavaScript. If something here does not show, that is our bug, not your limitation.
-
01
Origin of the mitochondrion
A symbiosis that enabled more complex cells.
-
02
Origin of the chloroplast
Captured light turned into living infrastructure.
-
03
Diversification
Plants, fungi and animals as branches, not as steps.
Scientific accuracy
This is a simplified educational diagram, not a timescale and not an exhaustive taxonomic tree. Early evolution also includes horizontal gene transfer and relationships more complex than a single line of descent.
Humans are a recent branch, not the goal of the process.
Engagement routes
Let us start at the right level of uncertainty.
Four ways to work with us. None is presented as a closed package, because scope is defined with the problem in front of us.
Explore
In validation
Opportunity sprint
Validate
Not built yet
Concept programme
Build
Not built yet
Development partnership
Research
Not built yet
Joint research
Exploratory. Nothing on this route is an approved treatment.
Frequently asked questions
Clear answers from an early stage.
Is 3 Marías commercially operating?
We are in a pre-launch demand-validation phase. Plant production exists and operates; the remaining units are in validation or in planning, and each one declares that above.
Are the food, medical and cosmetic solutions approved?
No. No blanket approval or automatic efficacy is implied. Every concept must earn its evidence through suitable testing, safety work and the regulatory route of its market.
Which companies should contact us?
Growers, micropropagation labs, food and personal-care companies, healthcare innovators, research groups and technical distributors that already have an identified problem.
Where will you work first?
Initial validation focuses on Mexico, followed by North America and Europe, with international collaboration possible from the start.
What does an initial engagement cost?
Terms are shaped with founding organisations. The first conversation adjusts scope, evidence and operating complexity before we propose a starting point.
Let's talk
Tell us where you work and what problem you have.
We use the conversation to understand demand, identify a credible starting point, and decide whether we are the right organisation. If we are not, we will say so.
What happens next
- A human reads your message. No automated reply decides for us.
- If there is a fit, we propose a thirty-minute call with a concrete agenda.
- If there is not, we tell you why and, where we can, point you to who is.
Enquiry received.
We will be in touch within one business day. If you prefer to write directly, use the address below.